| Year |
Citation |
Score |
| 2024 |
Shen T, Li S, Wang XS, Wang D, Wu S, Xia J, Zhang L. Deep reinforcement learning enables better bias control in benchmark for virtual screening. Computers in Biology and Medicine. 171: 108165. PMID 38402838 DOI: 10.1016/j.compbiomed.2024.108165 |
0.489 |
|
| 2023 |
Qin T, Gao X, Lei L, Feng J, Zhang W, Hu Y, Shen Z, Liu Z, Huan Y, Wu S, Xia J, Zhang L. Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease. European Journal of Medicinal Chemistry. 252: 115307. PMID 37003047 DOI: 10.1016/j.ejmech.2023.115307 |
0.51 |
|
| 2022 |
Qin T, Gao X, Lei L, Zhang W, Feng J, Wang X, Shen Z, Liu Z, Huan Y, Wu S, Xia J, Zhang L. Structural optimization and biological evaluation of 1-adamantylcarbonyl-4-phenylpiperazine derivatives as FXR agonists for NAFLD. European Journal of Medicinal Chemistry. 245: 114903. PMID 36375336 DOI: 10.1016/j.ejmech.2022.114903 |
0.498 |
|
| 2021 |
Jin H, Xia J, Liu Z, Simon Wang X, Zhang L. A unique ligand-steered strategy for CCR2 homology modeling to facilitate structure-based virtual screening. Chemical Biology & Drug Design. PMID 33386704 DOI: 10.1111/cbdd.13820 |
0.481 |
|
| 2020 |
Zhang H, He X, Wang X, Yu B, Zhao S, Jiao P, Jin H, Liu Z, Wang K, Zhang L, Zhang L. Design, synthesis and biological activities of piperidine-spirooxadiazole derivatives as α7 nicotinic receptor antagonists. European Journal of Medicinal Chemistry. 207: 112774. PMID 32882607 DOI: 10.1016/J.Ejmech.2020.112774 |
0.316 |
|
| 2020 |
Dou X, Huang H, Jiang L, Zhu G, Jin H, Jiao N, Zhang L, Liu Z, Zhang L. Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors. European Journal of Medicinal Chemistry. 201: 112445. PMID 32603981 DOI: 10.1016/J.Ejmech.2020.112445 |
0.364 |
|
| 2020 |
Lai J, Hu J, Wang Y, Zhou X, Li Y, Zhang L, Liu Z. Privileged Scaffold Analysis of Natural Products with Deep Learning-based Indication Prediction Model. Molecular Informatics. PMID 32406179 DOI: 10.1002/Minf.202000057 |
0.308 |
|
| 2020 |
Xia J, Wang Z, Huan Y, Xue W, Wang X, Wang YX, Liu ZM, Hsieh JH, Zhang LR, Wu S, Shen ZF, Zhang H, Wang XS. Pose Filter-based Ensemble Learning Enables Discovery of Orally Active, Nonsteroidal Farnesoid X Receptor Agonists. Journal of Chemical Information and Modeling. PMID 32050066 DOI: 10.1021/Acs.Jcim.9B01030 |
0.581 |
|
| 2019 |
Yang L, Liu Y, Fan M, Zhu G, Jin H, Liang J, Liu Z, Huang Z, Zhang L. Identification and characterization of benzo[d]oxazol-2(3H)-one derivatives as the first potent and selective small-molecule inhibitors of chromodomain protein CDYL. European Journal of Medicinal Chemistry. 182: 111656. PMID 31494467 DOI: 10.1016/J.Ejmech.2019.111656 |
0.368 |
|
| 2019 |
Xue Y, He X, Yang T, Wang Y, Liu Z, Zhang G, Wang Y, Wang K, Zhang L, Zhang L. Discovery of fused heterocyclic carboxamide derivatives as novel α7-nAChR agonists: Synthesis, preliminary SAR and biological evaluation. European Journal of Medicinal Chemistry. 182: 111618. PMID 31434041 DOI: 10.1016/J.Ejmech.2019.111618 |
0.336 |
|
| 2019 |
Dou X, Huang H, Li Y, Jiang L, Wang Y, Jin H, Jiao N, Zhang L, Zhang L, Liu Z. Multistage Screening Reveals 3-substituted Indolin-2-one Derivatives as Novel and Isoform Selective c-Jun N-terminal kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases. Journal of Medicinal Chemistry. PMID 31268308 DOI: 10.1021/Acs.Jmedchem.9B00537 |
0.317 |
|
| 2019 |
Zhao ZY, Xie XJ, Li WH, Liu J, Chen Z, Zhang B, Li T, Li SL, Lu JG, Zhang L, Zhang LH, Xu Z, Lee HC, Zhao YJ. A Cell-Permeant Mimetic of NMN Activates SARM1 to Produce Cyclic ADP-Ribose and Induce Non-apoptotic Cell Death. Iscience. 15: 452-466. PMID 31128467 DOI: 10.1016/J.Isci.2019.05.001 |
0.306 |
|
| 2019 |
Zhang L, Liu Z, Zhao Y, Jin H, Zhang L, Yang L, Shi X, Li S, Li T, Wu Y. Rational Design and Identification of Small-Molecule Allosteric Inhibitors of CD38. Chembiochem : a European Journal of Chemical Biology. PMID 31081167 DOI: 10.1002/Cbic.201900169 |
0.341 |
|
| 2019 |
Wang Y, Dou X, Jiang L, Jin H, Zhang L, Zhang L, Liu Z. Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia. European Journal of Medicinal Chemistry. 171: 221-234. PMID 30925338 DOI: 10.1016/J.Ejmech.2019.03.039 |
0.336 |
|
| 2018 |
Cao X, Zhang Y, Chen Y, Qiu Y, Yu M, Xu X, Liu X, Liu BF, Zhang L, Zhang G. Synthesis and biological evaluation of fused tricyclic heterocycle piperazine (piperidine) derivatives as potential multi-receptor atypical antipsychotics. Journal of Medicinal Chemistry. PMID 30383372 DOI: 10.1021/Acs.Jmedchem.8B01096 |
0.337 |
|
| 2018 |
Chen Y, Yuan X, Xiao Z, Jin H, Zhang L, Liu Z. Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening. Plos One. 13: e0205175. PMID 30321196 DOI: 10.1371/Journal.Pone.0205175 |
0.352 |
|
| 2018 |
Yang R, Chen Y, Pan L, Yang Y, Zheng Q, Hu Y, Wang Y, Zhang L, Sun Y, Li Z, Meng X. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors. Bioorganic & Medicinal Chemistry. PMID 30170925 DOI: 10.1016/J.Bmc.2018.08.028 |
0.367 |
|
| 2018 |
Xia J, Reid TE, Wu S, Zhang L, Wang XS. Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Its Comparative Analysis. Journal of Chemical Information and Modeling. PMID 29698608 DOI: 10.1021/Acs.Jcim.8B00004 |
0.567 |
|
| 2018 |
Chen Y, Tang Y, Mao B, Li W, Jin H, Zhang L, Liu Z. Discovery of N-(Naphtho[1,2-b]Furan-5-Yl) Benzenesulfonamides as Novel Selective Inhibitors of Triple-Negative Breast Cancer (TNBC). Molecules (Basel, Switzerland). 23. PMID 29547591 DOI: 10.3390/Molecules23030678 |
0.31 |
|
| 2018 |
Dou X, Jiang L, Wang Y, Jin H, Liu Z, Zhang L. Discovery of new GSK-3β inhibitors through structure-based virtual screening. Bioorganic & Medicinal Chemistry Letters. 28: 160-166. PMID 29208522 DOI: 10.1016/J.Bmcl.2017.11.036 |
0.311 |
|
| 2017 |
Luo X, Li M, Zhan K, Yang W, Zhang L, Wang K, Yu P, Zhang L. Selective inhibition of TRPM2 channel by two novel synthesized ADPR analogues. Chemical Biology & Drug Design. PMID 29034580 DOI: 10.1111/Cbdd.13119 |
0.362 |
|
| 2017 |
Chen C, Lu Y, Siu HM, Guan J, Zhu L, Zhang S, Yue J, Zhang L. Identification of Novel Vacuolin-1 Analogues as Autophagy Inhibitors by Virtual Drug Screening and Chemical Synthesis. Molecules (Basel, Switzerland). 22. PMID 28555021 DOI: 10.3390/Molecules22060891 |
0.347 |
|
| 2016 |
Zhang K, Sun W, Huang L, Zhu K, Zhu L, Wang Q, Lu Y, Zhang H, Jin H, Zhang LH, Zhang L, Yue J. Identifying GAPDH as a Cyclic Adenosine Diphosphoribose (cADPR) Binding Protein by Pho-toaffinity Protein-Ligand Labeling Approach. Journal of the American Chemical Society. PMID 27936653 DOI: 10.1021/Jacs.6B08088 |
0.311 |
|
| 2016 |
Wang H, Xu R, Shi Y, Si L, Jiao P, Fan Z, Han X, Wu X, Zhou X, Yu F, Zhang Y, Zhang L, Zhang L, Zhou D, Xiao S. Design, synthesis and biological evaluation of novel l-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors. European Journal of Medicinal Chemistry. 110: 376-388. PMID 26866456 DOI: 10.1016/J.Ejmech.2016.01.005 |
0.311 |
|
| 2015 |
Zeng L, Guan M, Jin H, Liu Z, Zhang L. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example. Chemical Biology & Drug Design. PMID 26072970 DOI: 10.1111/Cbdd.12607 |
0.309 |
|
| 2015 |
Zhang S, Xue X, Zhang L, Zhang L, Liu Z. Comparative Analysis of Pharmacophore Features and Quantitative Structure-Activity Relationships for CD38 Covalent and Non-covalent Inhibitors. Chemical Biology & Drug Design. PMID 26072680 DOI: 10.1111/Cbdd.12606 |
0.306 |
|
| 2015 |
Pei F, Jin H, Zhou X, Xia J, Sun L, Liu Z, Zhang L. Enrichment Assessment of Multiple Virtual Screening Strategies for Toll-Like Receptor 8 Agonists Based on a Maximal Unbiased Benchmarking Data Set. Chemical Biology & Drug Design. PMID 26017460 DOI: 10.1111/Cbdd.12590 |
0.525 |
|
| 2015 |
Xia J, Tilahun EL, Kebede EH, Reid TE, Zhang L, Wang XS. Comparative modeling and benchmarking data sets for human histone deacetylases and sirtuin families. Journal of Chemical Information and Modeling. 55: 374-88. PMID 25633490 DOI: 10.1021/Ci5005515 |
0.517 |
|
| 2015 |
Xia J, Tilahun EL, Reid TE, Zhang L, Wang XS. Benchmarking methods and data sets for ligand enrichment assessment in virtual screening. Methods (San Diego, Calif.). 71: 146-57. PMID 25481478 DOI: 10.1016/j.ymeth.2014.11.015 |
0.508 |
|
| 2014 |
Wang S, Zhu W, Wang X, Li J, Zhang K, Zhang L, Zhao YJ, Lee HC, Zhang L. Design, synthesis and SAR studies of NAD analogues as potent inhibitors towards CD38 NADase. Molecules (Basel, Switzerland). 19: 15754-67. PMID 25268725 DOI: 10.3390/Molecules191015754 |
0.316 |
|
| 2014 |
Xia J, Jin H, Liu Z, Zhang L, Wang XS. An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs. Journal of Chemical Information and Modeling. 54: 1433-50. PMID 24749745 DOI: 10.1021/Ci500062F |
0.518 |
|
| 2014 |
Zhan W, Li D, Che J, Zhang L, Yang B, Hu Y, Liu T, Dong X. Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitors. European Journal of Medicinal Chemistry. 75: 11-20. PMID 24508830 DOI: 10.1016/J.Ejmech.2014.01.019 |
0.365 |
|
| 2014 |
Liu T, Zhan W, Wang Y, Zhang L, Yang B, Dong X, Hu Y. Structure-based design, synthesis and biological evaluation of diphenylmethylamine derivatives as novel Akt1 inhibitors. European Journal of Medicinal Chemistry. 73: 167-76. PMID 24389511 DOI: 10.1016/J.Ejmech.2013.11.036 |
0.367 |
|
| 2014 |
Qiao X, Ji S, Yu SW, Lin XH, Jin HW, Duan YK, Zhang LR, Guo DA, Ye M. Identification of key licorice constituents which interact with cytochrome P450: evaluation by LC/MS/MS cocktail assay and metabolic profiling. The Aaps Journal. 16: 101-13. PMID 24254844 DOI: 10.1208/S12248-013-9544-9 |
0.304 |
|
| 2013 |
Deng Z, Gao ZC, Ge HQ, Zhang LR, Zhou JJ, Zhu ZP, Wu DY, Sun SY, Chen L, Pu XP. Treatment responses of procaterol and CD38 inhibitors in an ozone-induced airway hyperresponsiveness mice model. Biological & Pharmaceutical Bulletin. 36: 1348-55. PMID 23902978 DOI: 10.1248/Bpb.B13-00290 |
0.31 |
|
| 2013 |
Yu H, Jin H, Sun L, Zhang L, Sun G, Wang Z, Yu Y. Toll-like receptor 7 agonists: chemical feature based pharmacophore identification and molecular docking studies. Plos One. 8: e56514. PMID 23526932 DOI: 10.1371/Journal.Pone.0056514 |
0.332 |
|
| 2013 |
Huang W, Zuo T, Luo X, Jin H, Liu Z, Yang Z, Yu X, Zhang L, Zhang L. Indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors. Chemical Biology & Drug Design. 81: 730-41. PMID 23405965 DOI: 10.1111/Cbdd.12119 |
0.305 |
|
| 2013 |
Huang W, Zuo T, Jin H, Liu Z, Yang Z, Yu X, Zhang L, Zhang L. Design, synthesis and biological evaluation of indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors. Molecular Diversity. 17: 221-43. PMID 23378232 DOI: 10.1007/S11030-013-9424-3 |
0.34 |
|
| 2013 |
Wu D, Ting K, Duan Y, Li N, Li J, Zhang L, Lee H, Zhang L. Synthesis and activity of novel indole derivatives as inhibitors of CD38 Acta Pharmaceutica Sinica B. 3: 245-253. DOI: 10.1016/J.Apsb.2013.05.003 |
0.346 |
|
| 2012 |
Wang F, Chen Y, Huang Y, Jin HW, Zhang LR, Yang ZJ, Zhang LH. Synthesis, physicochemical and biological properties of oligonucleotides incorporated with amino-isonucleosides. Science China. Chemistry. 55: 70-79. PMID 32214999 DOI: 10.1007/S11426-011-4465-X |
0.302 |
|
| 2012 |
Wang Z, Sun L, Yu H, Zhang Y, Gong W, Jin H, Zhang L, Liang H. Binding mode pediction of evodiamine within vanilloid receptor TRPV1. International Journal of Molecular Sciences. 13: 8958-69. PMID 22942745 DOI: 10.3390/Ijms13078958 |
0.317 |
|
| 2012 |
Zhang J, Chen Y, Huang Y, Jin HW, Qiao RP, Xing L, Zhang LR, Yang ZJ, Zhang LH. Synthesis and properties of novel L-isonucleoside modified oligonucleotides and siRNAs. Organic & Biomolecular Chemistry. 10: 7566-77. PMID 22895883 DOI: 10.1039/C2Ob26219C |
0.318 |
|
| 2012 |
Zhou Y, Ting KY, Lam CM, Kwong AK, Xia J, Jin H, Liu Z, Zhang L, Cheung Lee H, Zhang L. Design, synthesis and biological evaluation of noncovalent inhibitors of human CD38 NADase. Chemmedchem. 7: 223-8. PMID 22287152 DOI: 10.1002/Cmdc.201100487 |
0.505 |
|
| 2012 |
Wang X, Zhang J, Huang Y, Wang R, Zhang L, Qiao K, Li L, Liu C, Ouyang Y, Xu W, Zhang Z, Zhang L, Shao Y, Jiang S, Ma L, et al. Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile. Journal of Medicinal Chemistry. 55: 2242-50. PMID 22283377 DOI: 10.1021/Jm201506E |
0.316 |
|
| 2012 |
Kwong AK, Chen Z, Zhang H, Leung FP, Lam CM, Ting KY, Zhang L, Hao Q, Zhang LH, Lee HC. Catalysis-based inhibitors of the calcium signaling function of CD38. Biochemistry. 51: 555-64. PMID 22142305 DOI: 10.1021/Bi201509F |
0.328 |
|
| 2011 |
Ma Y, Xu B, Fang Y, Yang Z, Cui J, Zhang L, Zhang L. Synthesis and SAR study of novel peptide aldehydes as inhibitors of 20S proteasome. Molecules (Basel, Switzerland). 16: 7551-64. PMID 21894088 DOI: 10.3390/Molecules16097551 |
0.32 |
|
| 2011 |
Dong M, Si YQ, Sun SY, Pu XP, Yang ZJ, Zhang LR, Zhang LH, Leung FP, Lam CM, Kwong AK, Yue J, Zhou Y, Kriksunov IA, Hao Q, Lee HC. Design, synthesis and biological characterization of novel inhibitors of CD38. Organic & Biomolecular Chemistry. 9: 3246-57. PMID 21431168 DOI: 10.1039/C0Ob00768D |
0.358 |
|
| 2011 |
Zhang H, Graeff R, Chen Z, Zhang L, Zhang L, Lee H, Hao Q. Dynamic conformations of the CD38-mediated NAD cyclization captured in a single crystal. Journal of Molecular Biology. 405: 1070-8. PMID 21134381 DOI: 10.1016/J.Jmb.2010.11.044 |
0.313 |
|
| 2010 |
Huang X, Dong M, Liu J, Zhang K, Yang Z, Zhang L, Zhang L. Concise syntheses of trifluoromethylated cyclic and acyclic analogues of cADPR. Molecules (Basel, Switzerland). 15: 8689-701. PMID 21119564 DOI: 10.3390/Molecules15128689 |
0.341 |
|
| 2010 |
Li L, Siebrands CC, Yang Z, Zhang L, Guse AH, Zhang L. Novel nucleobase-simplified cyclic ADP-ribose analogue: A concise synthesis and Ca(2+)-mobilizing activity in T-lymphocytes. Organic & Biomolecular Chemistry. 8: 1843-8. PMID 20449488 DOI: 10.1039/B925295A |
0.338 |
|
| 2010 |
Qin H, Liu C, Zhang J, Guo Y, Zhang S, Zhang Z, Wang X, Zhang L, Liu J. Synthesis and biological evaluation of novel 2-arylalkylthio-4-amino-6-benzyl pyrimidines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 3003-5. PMID 20347295 DOI: 10.1016/J.Bmcl.2009.04.051 |
0.311 |
|
| 2010 |
Zhu Y, Zhu X, Wu G, Ma Y, Li Y, Zhao X, Yuan Y, Yang J, Yu S, Shao F, Li R, Ke Y, Lu A, Liu Z, Zhang L. Synthesis, in vitro and in vivo biological evaluation, docking studies, and structure--activity relationship (SAR) discussion of dipeptidyl boronic acid proteasome inhibitors composed of beta-amino acids. Journal of Medicinal Chemistry. 53: 1990-9. PMID 20158184 DOI: 10.1021/Jm901407S |
0.32 |
|
| 2010 |
Wu H, Yang Z, Zhang L, Zhang L. Concise synthesis of novel acyclic analogues of cADPR with an ether chain as the northern moiety New Journal of Chemistry. 34: 956-966. DOI: 10.1039/B9Nj00595A |
0.344 |
|
| 2009 |
Zhang S, Shi Y, Jin H, Liu Z, Zhang L, Zhang L. Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study. Journal of Molecular Modeling. 15: 1481-90. PMID 19440739 DOI: 10.1007/S00894-009-0515-0 |
0.305 |
|
| 2009 |
Xu Y, Jin H, Yang Z, Zhang L, Wang Q, Li M, Zhang L. Synthesis and evaluation of novel neamine derivatives effectively targeting to RNA. Bioorganic & Medicinal Chemistry Letters. 19: 2103-6. PMID 19327991 DOI: 10.1016/J.Bmcl.2009.03.021 |
0.323 |
|
| 2009 |
Zhang Z, Wu J, Ran F, Guo Y, Tian R, Zhou S, Wang X, Liu Z, Zhang L, Cui J, Liu J. Novel 8-deaza-5,6,7,8-tetrahydroaminopterin derivatives as dihydrofolate inhibitor: design, synthesis and antifolate activity. European Journal of Medicinal Chemistry. 44: 764-71. PMID 18555562 DOI: 10.1016/J.Ejmech.2008.04.017 |
0.361 |
|
| 2008 |
Barbault F, Ren B, Rebehmed J, Teixeira C, Luo Y, Smila-Castro O, Maurel F, Fan B, Zhang L, Zhang L. Flexible computational docking studies of new aminoglycosides targeting RNA 16S bacterial ribosome site. European Journal of Medicinal Chemistry. 43: 1648-56. PMID 18096272 DOI: 10.1016/J.Ejmech.2007.10.022 |
0.311 |
|
| 2008 |
Zhang L, Han T, Liu Y, Yang Z, Zhang L. Stereospecific Synthesis of
Eight-Membered Polyhydroxy Carbocycles via TIBAL-Promoted
Claisen Rearrangement Synlett. 2008: 1985-1988. DOI: 10.1055/S-2008-1077965 |
0.324 |
|
| 2008 |
Li L, Lin B, Yang Z, Zhang L, Zhang L. A concise route for the preparation of nucleobase-simplified cADPR mimics by click chemistry Tetrahedron Letters. 49: 4491-4493. DOI: 10.1016/J.Tetlet.2008.05.076 |
0.321 |
|
| 2007 |
Yu H, Wang Z, Zhang L, Zhang J, Huang Q. The discovery of novel vascular endothelial growth factor receptor tyrosine kinases inhibitors: pharmacophore modeling, virtual screening and docking studies. Chemical Biology & Drug Design. 69: 204-11. PMID 17441906 DOI: 10.1111/J.1747-0285.2007.00488.X |
0.317 |
|
| 2007 |
Yu H, Wang Z, Zhang L, Zhang J, Huang Q. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 2126-33. PMID 17306530 DOI: 10.1016/J.Bmcl.2007.01.089 |
0.337 |
|
| 2006 |
Xu J, Yang Z, Dammermann W, Zhang L, Guse AH, Zhang LH. Synthesis and agonist activity of cyclic ADP-ribose analogues with substitution of the northern ribose by ether or alkane chains. Journal of Medicinal Chemistry. 49: 5501-12. PMID 16942023 DOI: 10.1021/Jm060320E |
0.328 |
|
| 2005 |
Wang Z, Zhang L, Lu J, Zhang L. Analysis of the interactions of ribonuclease inhibitor with kanamycin. Journal of Molecular Modeling. 11: 80-6. PMID 15645301 DOI: 10.1007/S00894-004-0229-2 |
0.302 |
|
| 2004 |
Wang J, Zhang L, Yang Z, Zhang L. Synthesis and biological evaluation of 6-substituted purine and 9-β-d-ribofuranosyl purine analogues Bioorganic & Medicinal Chemistry. 12: 1425-1429. PMID 15018915 DOI: 10.1016/J.Bmc.2004.01.005 |
0.356 |
|
| 2003 |
Wang X, Niu Y, Cao X, Zhang L, Zhang LH, Ye XS. 3D-QSAR analysis of sialyltransferase inhibitors. Bioorganic & Medicinal Chemistry. 11: 4217-24. PMID 12951152 DOI: 10.1016/S0968-0896(03)00489-9 |
0.328 |
|
| 2002 |
Zhang L, Zhang Y, Li X, Zhang L. Study on the synthesis and PKA-I binding activities of 5-alkynyl tubercidin analogues. Bioorganic & Medicinal Chemistry. 10: 907-12. PMID 11836097 DOI: 10.1016/S0968-0896(01)00341-8 |
0.33 |
|
| 1996 |
Yu H, Zhang L, Zhou J, Ma L, Zhang L. Studies on the synthesis and biological activities of 4′-(R)-hydroxy-5′-(S)-hydroxymethyl-tetrahydrofuranyl purines and pyrimidines Bioorganic & Medicinal Chemistry. 4: 609-614. PMID 8735849 DOI: 10.1016/0968-0896(96)00048-X |
0.317 |
|
| Show low-probability matches. |